Mutual of America Capital Management’s TG Therapeutics TGTX Stock Holding History

Mutual of America Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.86M	Buy	88,548 +72,988	+469%	+$2.99M	0.05%	446
2026 Q1	$517K	Buy	15,560 +20	+0.1%	+$596	0.01%	1056
2025 Q4	$463K	Buy	15,540 +341	+2%	+$11.1K	﹤0.01%	1083
2025 Q3	$549K	Sell	15,199 -2,221	-13%	-$73.2K	0.01%	1052
2025 Q2	$627K	Sell	17,420 -2,017	-10%	-$75.1K	0.01%	1043
2025 Q1	$766K	Sell	19,437 -782	-4%	-$26.3K	0.01%	1036
2024 Q4	$609K	Buy	20,219 +155	+0.8%	+$4.45K	0.01%	1088
2024 Q3	$469K	Buy	+20,064	New	+$438K	﹤0.01%	1164

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Mutual of America Capital Management's TGTX Position: Q2 2026 in Review

Mutual of America Capital Management increased its TG Therapeutics (TGTX) stake by 469% in Q2 2026, buying an estimated $2.99M and bringing the position to 88,548 shares worth $4.86M. The position accounts for 0.05% of the portfolio, ranked #446.

Mutual of America Capital Management first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 272 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Mutual of America Capital Management held 88,548 shares of TG Therapeutics worth $4.86M as of Q2 2026.
Mutual of America Capital Management bought 72,988 TG Therapeutics shares in Q2 2026, an estimated $2.99M.
TG Therapeutics made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #446 holding.
Mutual of America Capital Management first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
272 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.